History | Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma | Guidance | NICE

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 225 KB)

Published:

13 June 2018

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 500 KB)

Published:

04 May 2018
Committee papers (PDF 10.69 MB)

Published:

04 May 2018
Public committee slides (PDF 601 KB)

Published:

04 May 2018

Invitation to participate

Final scope (PDF 213 KB)

Published:

13 December 2017
Final matrix (PDF 308 KB)

Published:

13 December 2017